Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 18 citing articles:

Pancreatic cancer environment: from patient-derived models to single-cell omics
Ao Gu, Jiatong Li, Shimei Qiu, et al.
Molecular Omics (2024) Vol. 20, Iss. 4, pp. 220-233
Closed Access | Times Cited: 24
Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay
Jose L. Mira, Arnaud Quentel, Ranish K. Patel, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 785
Closed Access | Times Cited: 2
Data-Independent Acquisition: A Milestone and Prospect in Clinical Mass Spectrometry–Based Proteomics
Klemens Fröhlich, Matthias Fahrner, Eva Brombacher, et al.
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 8, pp. 100800-100800
Open Access | Times Cited: 9
Dynamic evaluation of postoperative survival in pancreatic ductal adenocarcinoma
Bowen Zheng, Xinyu Yang, Jun Zheng, et al.
Medicine (2025) Vol. 104, Iss. 12, pp. e41942-e41942
Open Access
Mass spectrometry‐based proteomic applications in dental implants research
Tim Halstenbach, Annika Topitsch, Oliver Schilling, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2024) Vol. 18, Iss. 3
Open Access | Times Cited: 3
Integration of proteomics in the molecular tumor board
Johanna Thiery, Matthias Fahrner
PROTEOMICS (2023) Vol. 24, Iss. 12-13
Open Access | Times Cited: 7
Neoadjuvant chemo‐ or chemo‐radiation‐therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass
Maren Nicole Stillger, Konrad Kurowski, Peter Bronsert, et al.
International Journal of Cancer (2024) Vol. 154, Iss. 12, pp. 2162-2175
Open Access | Times Cited: 2
The serum proteome of VA-ECMO patients changes over time and allows differentiation of survivors and non-survivors: an observational study
Patrick M. Siegel, Bálint András Barta, Lukas Orlean, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Evaluating the Molecular Properties and Function of ANKHD1, and Its Role in Cancer
Jordan L. Mullenger, Martin P. Zeidler, Maria Fragiadaki
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12834-12834
Open Access | Times Cited: 4
Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics
Ashok Kumar Balaraman, Ehssan Moglad, Muhammad Afzal, et al.
Clinica Chimica Acta (2024), pp. 120105-120105
Closed Access | Times Cited: 1
Einsatz der Proteomik bei der Stratifizierung und Prognoseabschätzung solider Tumoren
Tilman Werner, Matthias Fahrner, Oliver Schilling
Deleted Journal (2023) Vol. 44, Iss. S3, pp. 176-182
Closed Access | Times Cited: 3
Assessing the performance of docking, FEP, and MM/GBSA methods on a series of KLK6 inhibitors
Wemenes José Lima Silva, Renato Ferreira de Freitas
Journal of Computer-Aided Molecular Design (2023) Vol. 37, Iss. 9, pp. 407-418
Closed Access | Times Cited: 2
Proteomic analysis of non‐muscle invasive and muscle invasive bladder cancer highlights distinct subgroups with metabolic, matrisomal, and immune hallmarks and emphasizes importance of the stromal compartment
Thien‐Ly Julia Dinh, Manuel Rogg, Miguel Cosenza‐Contreras, et al.
The Journal of Pathology (2024) Vol. 265, Iss. 1, pp. 41-56
Closed Access
Integration of proteomics in the molecular tumor board
Johanna Thiery, Matthias Fahrner
Authorea (Authorea) (2023)
Open Access | Times Cited: 1
Positional proteomics: is the technology ready to study clinical cohorts?
Philipp F. Lange, Oliver Schilling, Pitter F. Huesgen
Expert Review of Proteomics (2023) Vol. 20, Iss. 12, pp. 309-318
Closed Access | Times Cited: 1
Mass Spectrometry-based Proteomics Technology in Pancreatic Cancer Research
Xue Sun, Siyuan Wang, Catherine C. L. Wong
Journal of Pancreatology (2023) Vol. 7, Iss. 2, pp. 145-163
Open Access | Times Cited: 1
Neoadjuvant Chemotherapy or Combined Chemo-Radiation Therapy of Pancreatic Ductal Adenocarcinoma Differentially Shift Immune Activation, ECM Composition, Energy Metabolism, and Ribosomal Proteins of the Residual Tumor Mass
Maren Nicole Stillger, Peter Bronsert, Eva Brombacher, et al.
Research Square (Research Square) (2023)
Open Access
Assessing the Performance of Docking, FEP, and MM/GBSA Methods on a Series of KLK6 Inhibitors
Wemenes José Lima Silva, Renato Ferreira de Freitas
(2023)
Open Access
Page 1

Scroll to top